Drawing for PROMETHEUS BIOSCIENCES

USPTO serial 88596244

PROMETHEUS BIOSCIENCES

Reviewed by CopyMark Law Group

Reg. 6449447Status 700Renewal
Filing date
Status date
Registration date
Aug 10, 2021
Examiner
GILBERT, HANNAH B
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PROMETHEUS BIOSCIENCES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brent D. Sokol

Brent D. Sokol Greenberg Traurig, LLP1840 Century Park East, Suite 1900Los Angeles, CA 90067UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, biopharmaceutical and therapeutic preparations and substances for the diagnosis, prevention and treatment of gastro-intestinal diseases; Pharmaceutical, biopharmaceutical and therapeutic preparations and substances for the diagnosis, prevention and treatment of colitis, Crohn's disease, and other diseases of the immune, digestive, bowel and gastro-intestinal systems; Diagnostic preparations for medical purposesACTIVEDec 13, 2019
042Providing medical and scientific research information in the field of pharmaceuticals and clinical trials to medical and research professionals; providing a website featuring information about investigational medical devices for the diagnosis, prevention, and treatment of gastro-intestinal diseases, colitis, Crohn's disease, and other diseases of the immune, digestive, bowel, and gastro-intestinal systems; providing a website featuring information about medical diagnostics and drugs; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics; development of pharmaceutical preparations and medicinesACTIVEApr 28, 2020
044Providing health information in the field of gastro-intestinal diseases, colitis, Crohn's disease, and other diseases of the immune, digestive, bowel and gastro-intestinal systems; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consultationACTIVEApr 28, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 10, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 3, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 3, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 3, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 10, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 7, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 6, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 11, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2021ALIEASSIGNED TO LIE—
Jun 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 30, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 29, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 29, 2020EX1GSOU EXTENSION 1 GRANTED—
Oct 26, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 15, 2020IUAFUSE AMENDMENT FILED—
Oct 15, 2020EXT1SOU EXTENSION 1 FILED—
Oct 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 15, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 21, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 25, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 17, 2020ALIEASSIGNED TO LIE—
Jan 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 14, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 14, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 14, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 5, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 5, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 5, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 5, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 2, 2019DOCKASSIGNED TO EXAMINER—
Oct 23, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance